SOMATULINE AUTOGEL

Google image searchProduct monograph

Active ingredient

lanreotide (lanreotide acetate), 120 MG/SYR

DIN: 02283417

Dosage form(s): SOLUTION (EXTENDED RELEASE)

Route(s) of administration: SUBCUTANEOUS

Description: PRE-FILLED SYRINGE

Schedule: Prescription

Company: IPSEN BIOPHARMACEUTICALS CANADA INC

Date: 15-DEC-2021

ATC:

Reference brand drug: Somatuline

Search on Google